Peptides Archives

Alume Biosciences announces first patient dosed with ALM 488

News and Trends 23 Aug 2022

Alume Biosciences progressing with fluorescence study in patients undergoing head and neck surgery

Alume Biosciences, Inc. says the first patient has been dosed in a phase 3 pivotal study of ALM-488, a peptide-dye conjugate designed to highlight nerves with fluorescence in real time during surgery. “The successful initiation of this phase 3 pivotal study is another major milestone for Alume Biosciences. It marks the final phase of clinical […]

August 23, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 10 Aug 2022

Captor Therapeutics names lead candidate in fight against hepatocellular carcinoma

A Polish biopharma company focused on treating cancer and autoimmune diseases announced today (August 10) that it has chosen a lead candidate for the treatment of hepatocellular carcinoma. The molecular glue candidate, CPT-6281 will be Captor Therapeutic’s CT-01 project which will initially focus on the clinical development of the asset as a targeted protein degradation […]

August 10, 2022 - 3 minutesmins - By Liza Laws

News and Trends 28 Jun 2022

Micropep raises €8.75M to develop alternative crop-protection products

French ag-biotech company Micropep, which develops biological micropeptide-based solutions for agriculture, has completed an €8.75 million ($9.3 million) series A1 financing round. Fall Line Capital led the funding, in addition to existing investors, Supernova Invest, Sofinnova Partners, FMC Ventures and IRDI/SORIDEC. Based in Toulouse, Micropep has developed a technological platform that makes it possible to […]

June 28, 2022 - 3 minutesmins - By Jim Cornall

Interview 9 May 2019

A 20-Year Journey to Nail Down an Undruggable Cancer Target

The ultimate goal of cancer research is to bring to the market a drug that improves the treatment of patients lacking options. Laura Soucek, CEO of the startup Peptomyc, shares the story of her journey to take a cancer treatment against an until now undruggable target to the clinic. It all started when Soucek was […]

May 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 2 Jul 2018

Dutch Snake Venom-Derived Clotting Agent Comes Closer to the Clinic

Dutch biotech raises €12.5M to complete the preclinical development of its lead compound for acute internal bleeding and bring the drug into clinical trials. VarmX, based in Leiden, the Netherlands, raised a Series A round of €7.5M led by BioGeneration Ventures, with an additional €5M provided by the Netherlands Enterprise Agency as an Innovation Credit. The […]

July 2, 2018 - 1 minutemin - By Alexander Burik

Startup Scout 1 Jun 2018

This Dutch Biotech Gets Inspiration From Snake Venom to Restore Blood Clotting

This week we’re in Leiden, the Netherlands, visiting VarmX. The biotech develops therapeutic proteins based on a peptide found in snake venom to restore blood clotting in patients with acute bleeding. Mission: Founded in 2016 as a spin-out from the University of Leiden, VarmX aims to restore blood clotting in patients with acute, internal bleeding after taking […]

June 1, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 18 May 2018

This French Biotech Targets Retinal Cells to Treat Blindness

Today, we’re in Paris, visiting SparingVision, a biotech trying to combat blindness using a protein that slows down the degeneration of cone cells in the retina. Mission: SparingVision uses a naturally occurring protein called rod-derived cone-viability factor, which binds to a transmembrane peptide on cone photoreceptor cells in the retina and allows more glucose to enter […]

May 18, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 11 May 2018

This Oxford Biotech is Using DNA to Find New Peptide Drugs

Today, we’re in Oxford, UK, visiting Orbit Discovery. The biotech develops peptide drugs for chronic diseases using DNA to tag potential therapeutic proteins. Mission: Orbit Discovery develops peptide drugs for a range of conditions including metabolic, autoimmune and cardiovascular diseases using beads to connect peptides to the DNA that encodes them and see how well the peptides […]

May 11, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Mar 2018

French Biotech Uses Natural Peptides to Boost Plant Growth and Immunity

Micropep Technologies, a Toulouse-based biotech, has raised €4M to develop peptides that boost plant growth and disease resistance by regulating gene expression. Micropep Technologies has raised a Series A funding with the support of two new investors, Sofinnova Partners, the largest industrial biotech fund in the world, and Irdi Soridec Gestion. The company aims to use the funding […]

March 6, 2018 - 3 minutesmins - By Alexander Burik

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

The use of opioids and non-steroidal anti-inflammatory drugs (NSAIDs) is a massive public health issue. I spoke with Simon Westbrook, CEO of Levicept, whose new approach to pain relief, which is being tested for osteoarthritis, could be a game-changer. Back in September, a couple of weeks into my time at Labiotech, I got the chance […]

February 26, 2018 - 9 minutesmins - By Alex Dale

artificial intelligence peptides nuritas 1

News and Trends 14 Feb 2018

Nestlé and AI Biotech Hunt Down Bioactive Peptides in Our Food

Nuritas and Nestlé will use artificial intelligence to find bioactive peptides in the food we eat for applications including diabetes, anti-aging, and animal and plant health. Nuritas wants to revolutionize the discovery of natural active ingredients that can support and improve human health. The company uses artificial intelligence (AI) to look closely at the foods we […]

February 14, 2018 - 3 minutesmins - By Alex Dale

antibiotics resistance peptides Aelin3 Edited

News and Trends 13 Dec 2017

New Belgian Biotech Secures €27M Series A to Develop Peptide Antibiotics

Aelin Therapeutics will develop its Pept-in technology, which could hold the answer to the growing antibiotics resistance crisis. Aelin Therapeutics is a Belgian biotherapeutics company that is hoping to pioneer Pept-in, protein knockdown drugs that could revolutionize the antibiotics field and open up previously undruggable targets. The company was founded by VIB and partner universities […]

December 13, 2017 - 3 minutesmins - By Alex Dale

Resources

Categories

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Approaches

Therapeutic areas

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us